Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 3022 entries
Sorted by: Best Match Show Resources per page
Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion …

Stem career interventions

[No authors listed]
GSID: doj-kkLWf9MJ
J Eggers, IR König, B Koch, G Händler, G Seidel - Stroke, 2008 - Am Heart Assoc

Background and Purpose—Sonothrombolysis is a new treatment approach in acute ischemic stroke. The results of a monocenter, randomized clinical study are presented. Methods—Subjects with acute middle cerebral artery main stem occlusion were randomized into a target group receiving 1-hour...

Cite
Eggers, J., König, I. R., Koch, B., Händler, G., & Seidel, G. (2008). Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study. Stroke, 39(5), 1470-1475.
Eggers, Jürgen, et al. "Sonothrombolysis with transcranial color-coded sonography and recombinant tissue-type plasminogen activator in acute middle cerebral artery main stem occlusion: results from a randomized study." Stroke 39.5 (2008): 1470-1475.
Copy Download .nbib Format: MLA
Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

evaluation

Parsons MW, Levi C.
GSID: z86lng8dYwkJ
SM Davis, GA Donnan, MW Parsons, C Levi… - The Lancet …, 2008 - Elsevier

Background Whether intravenous tissue plasminogen activator (alteplase) is effective beyond 3 h after onset of acute ischaemic stroke is unclear. We aimed to test whether alteplase given 3–6 h after stroke onset promotes reperfusion and attenuates infarct growth in...

Cite
Davis, S. M., Donnan, G. A., Parsons, M. W., Levi, C., Butcher, K. S., Peeters, A., ... & Desmond, P. M. (2008). Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial. The Lancet Neurology, 7(4), 299-309.
Davis, Stephen M., et al. "Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial." The Lancet Neurology 7.4 (2008): 299-309.
Copy Download .nbib Format: MLA
Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain …

Stem career interventions

[No authors listed]
GSID: W6AZFw8gGRkJ
PM Kidd - Alternative Medicine Review, 2009 - search.ebscohost.com

Brain injury from ischemic stroke can be devastating, but full brain restoration is feasible. Time until treatment is critical; rapid rate of injury progression, logistical and personnel constraints on neurological and cardiovascular assessment, limitations of recombinant tissue plasminogen activator...

Cite
Kidd, P. M. (2009). Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity. Alternative Medicine Review, 14(1).
Kidd, Parris M. "Integrated brain restoration after ischemic stroke--medical management, risk factors, nutrients, and other interventions for managing inflammation and enhancing brain plasticity." Alternative Medicine Review 14.1 (2009).
Copy Download .nbib Format: MLA
Mechanisms of ischemic neuroprotection by acetyl‐L‐carnitine

Stem education interventions

[No authors listed]
GSID: KsLczek0oF8J
SA Zanelli, NJ Solenski, RE Rosenthal… - Annals of the New …, 2005 - Wiley Online Library

… At this juncture, the only neuroprotective interventions demonstrated to be efficacious in large, multicenter clinical trials include administration of tissue plasminogen factor (TPA) to …

Cite
Zanelli, S. A., Solenski, N. J., Rosenthal, R. E., & Fiskum, G. (2005). Mechanisms of ischemic neuroprotection by acetyl‐L‐carnitine. Annals of the New York Academy of Sciences, 1053(1), 153-161.
Zanelli, Santina A., et al. "Mechanisms of ischemic neuroprotection by acetyl‐L‐carnitine." Annals of the New York Academy of Sciences 1053.1 (2005): 153-161.
Copy Download .nbib Format: MLA
Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes.

Diabetology & metabolic syndrome

Zajdenverg L, Rodacki M, Faria JP, Pires ML, Oliveira JE, Halfoun VL.
PMID: 24955136
Diabetol Metab Syndr. 2014 May 26;6:63. doi: 10.1186/1758-5996-6-63. eCollection 2014.

UNLABELLED: Previous gestational diabetes mellitus (pGDM) indicates future risk for type 2 diabetes (T2DM). Insulin resistance (IR) may precede T2DM in many years and is associated with an increased risk for cardiovascular diseases.AIM: This study aims to identify endothelial...

Cite
Zajdenverg L, Rodacki M, Faria JP, et al. Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes. Diabetol Metab Syndr. 2014;6:63doi: 10.1186/1758-5996-6-63.
Zajdenverg, L., Rodacki, M., Faria, J. P., Pires, M. L., Oliveira, J. E., & Halfoun, V. L. (2014). Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes. Diabetology & metabolic syndrome, 663. https://doi.org/10.1186/1758-5996-6-63
Zajdenverg, Lenita, et al. "Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes." Diabetology & metabolic syndrome vol. 6 (2014): 63. doi: https://doi.org/10.1186/1758-5996-6-63
Zajdenverg L, Rodacki M, Faria JP, Pires ML, Oliveira JE, Halfoun VL. Precocious markers of cardiovascular risk and vascular damage in apparently healthy women with previous gestational diabetes. Diabetol Metab Syndr. 2014 May 26;6:63. doi: 10.1186/1758-5996-6-63. eCollection 2014. PMID: 24955136; PMCID: PMC4064263.
Copy Download .nbib Format: NLM
Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis.

Anesthesiology and pain medicine

Nouri M, Ahmadi A, Etezadi F, Barzegar E, Mojtahedzadeh M.
PMID: 27252904
Anesth Pain Med. 2016 Apr 02;6(2):e33780. doi: 10.5812/aapm.33780. eCollection 2016 Apr.

BACKGROUND: Sepsis is the result of the interaction between inflammatory mediators and coagulation pathway. Unfractionated heparin may play a role as an anti-inflammatory agent beyond its anticoagulatory effect in sepsis. As a result, it may cause reduction in organ...

Cite
Nouri M, Ahmadi A, Etezadi F, et al. Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis. Anesth Pain Med. 2016;6(2):e33780doi: 10.5812/aapm.33780.
Nouri, M., Ahmadi, A., Etezadi, F., Barzegar, E., & Mojtahedzadeh, M. (2016). Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis. Anesthesiology and pain medicine, 6(2), e33780. https://doi.org/10.5812/aapm.33780
Nouri, Masoumeh, et al. "Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis." Anesthesiology and pain medicine vol. 6,2 (2016): e33780. doi: https://doi.org/10.5812/aapm.33780
Nouri M, Ahmadi A, Etezadi F, Barzegar E, Mojtahedzadeh M. Comparison of the Effects of Subcutaneous Versus Continuous Infusion of Heparin on Key Inflammatory Parameters Following Sepsis. Anesth Pain Med. 2016 Apr 02;6(2):e33780. doi: 10.5812/aapm.33780. eCollection 2016 Apr. PMID: 27252904; PMCID: PMC4886623.
Copy Download .nbib Format: NLM
Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids.

Aging and disease

Cai M, Zhang W, Weng Z, Stetler RA, Jiang X, Shi Y, Gao Y, Chen J.
PMID: 28966799
Aging Dis. 2017 Oct 01;8(5):531-545. doi: 10.14336/AD.2017.0520. eCollection 2017 Oct.

The aged population is among the highest at risk for ischemic stroke, yet most stroke patients of advanced ages (>80 years) are excluded from access to thrombolytic treatment by tissue plasminogen activator, the only FDA approved pharmacological therapy for...

Cite
Cai M, Zhang W, Weng Z, et al. Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids. Aging Dis. 2017;8(5):531-545doi: 10.14336/AD.2017.0520.
Cai, M., Zhang, W., Weng, Z., Stetler, R. A., Jiang, X., Shi, Y., Gao, Y., & Chen, J. (2017). Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids. Aging and disease, 8(5), 531-545. https://doi.org/10.14336/AD.2017.0520
Cai, Mengfei, et al. "Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids." Aging and disease vol. 8,5 (2017): 531-545. doi: https://doi.org/10.14336/AD.2017.0520
Cai M, Zhang W, Weng Z, Stetler RA, Jiang X, Shi Y, Gao Y, Chen J. Promoting Neurovascular Recovery in Aged Mice after Ischemic Stroke - Prophylactic Effect of Omega-3 Polyunsaturated Fatty Acids. Aging Dis. 2017 Oct 01;8(5):531-545. doi: 10.14336/AD.2017.0520. eCollection 2017 Oct. PMID: 28966799; PMCID: PMC5614319.
Copy Download .nbib Format: NLM
Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis.

Journal of neurosciences in rural practice

Dharmasaroja PA, Muengtaweepongsa S.
PMID: 26933341
J Neurosci Rural Pract. 2016 Jan-Mar;7(1):36-9. doi: 10.4103/0976-3147.172149.

BACKGROUND: Many thrombolytic studies showed that severe stroke was associated with death and having symptomatic intracerebral hemorrhage and inversely related to a favorable outcome.AIMS: The purpose of this study is to compare the outcomes of patients with acute large...

Cite
Dharmasaroja PA, Muengtaweepongsa S. Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. J Neurosci Rural Pract. 2016;7(1):36-9doi: 10.4103/0976-3147.172149.
Dharmasaroja, P. A., & Muengtaweepongsa, S. (2016). Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. Journal of neurosciences in rural practice, 7(1), 36-9. https://doi.org/10.4103/0976-3147.172149
Dharmasaroja, Pornpatr A, and Muengtaweepongsa, Sombat. "Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis." Journal of neurosciences in rural practice vol. 7,1 (2016): 36-9. doi: https://doi.org/10.4103/0976-3147.172149
Dharmasaroja PA, Muengtaweepongsa S. Outcomes of patients with large middle cerebral artery infarct treated with and without intravenous thrombolysis. J Neurosci Rural Pract. 2016 Jan-Mar;7(1):36-9. doi: 10.4103/0976-3147.172149. PMID: 26933341; PMCID: PMC4750336.
Copy Download .nbib Format: NLM
Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal.

Journal of neurosciences in rural practice

Thapa L, Shrestha S, Shrestha P, Bhattarai S, Gongal DN, Devkota UP.
PMID: 26933345
J Neurosci Rural Pract. 2016 Jan-Mar;7(1):55-60. doi: 10.4103/0976-3147.172161.

BACKGROUND: Stroke is the major cause of morbidity and mortality worldwide. The number of stroke patients receiving recombinant tissue plasminogen activator (rt-PA), also known as Alteplase, in the developing world is extremely low. We aim to study the feasibility...

Cite
Thapa L, Shrestha S, Shrestha P, et al. Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal. J Neurosci Rural Pract. 2016;7(1):55-60doi: 10.4103/0976-3147.172161.
Thapa, L., Shrestha, S., Shrestha, P., Bhattarai, S., Gongal, D. N., & Devkota, U. P. (2016). Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal. Journal of neurosciences in rural practice, 7(1), 55-60. https://doi.org/10.4103/0976-3147.172161
Thapa, Lekhjung, et al. "Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal." Journal of neurosciences in rural practice vol. 7,1 (2016): 55-60. doi: https://doi.org/10.4103/0976-3147.172161
Thapa L, Shrestha S, Shrestha P, Bhattarai S, Gongal DN, Devkota UP. Feasibility and efficacy of thrombolysis in acute ischemic stroke: A study from National Institute of Neurological and Allied Sciences, Kathmandu, Nepal. J Neurosci Rural Pract. 2016 Jan-Mar;7(1):55-60. doi: 10.4103/0976-3147.172161. PMID: 26933345; PMCID: PMC4750341.
Copy Download .nbib Format: NLM
Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS.

Experimental and therapeutic medicine

Zhao H, Zhang J, Gu D, Shi Z, Pan J, Geng Y, Shi T.
PMID: 28912883
Exp Ther Med. 2017 Oct;14(4):3314-3318. doi: 10.3892/etm.2017.4856. Epub 2017 Jul 31.

The aim of the present study was to assess the use of tirofiban injections for rescue therapy following artery reocclusion due to intra-luminal thrombosis during endovascular thrombectomy in patients with acute ischemic stroke (AIS). A total of seven cases...

Cite
Zhao H, Zhang J, Gu D, et al. Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS. Exp Ther Med. 2017;14(4):3314-3318doi: 10.3892/etm.2017.4856.
Zhao, H., Zhang, J., Gu, D., Shi, Z., Pan, J., Geng, Y., & Shi, T. (2017). Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS. Experimental and therapeutic medicine, 14(4), 3314-3318. https://doi.org/10.3892/etm.2017.4856
Zhao, Hongchen, et al. "Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS." Experimental and therapeutic medicine vol. 14,4 (2017): 3314-3318. doi: https://doi.org/10.3892/etm.2017.4856
Zhao H, Zhang J, Gu D, Shi Z, Pan J, Geng Y, Shi T. Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS. Exp Ther Med. 2017 Oct;14(4):3314-3318. doi: 10.3892/etm.2017.4856. Epub 2017 Jul 31. PMID: 28912883; PMCID: PMC5585762.
Copy Download .nbib Format: NLM
Central Venous Catheters for Hemodialysis: How to Overcome the Problems.

Hemodialysis international. International Symposium on Home Hemodialysis

Davenport A.
PMID: 28455926
Hemodial Int. 2000 Jan;4(1):78-82. doi: 10.1111/hdi.2000.4.1.78.

The use of central venous dialysis catheters is increasing in clinical practice. These devices, although relatively easy to insert, do have problems. Catheter size limits the amount of dialysis that can be delivered. Central venous hemodialysis catheters minimize cardiopulmonary...

Cite
Davenport A. Central Venous Catheters for Hemodialysis: How to Overcome the Problems. Hemodial Int. 2000;4(1):78-82doi: 10.1111/hdi.2000.4.1.78.
Davenport, A. (2000). Central Venous Catheters for Hemodialysis: How to Overcome the Problems. Hemodialysis international. International Symposium on Home Hemodialysis, 4(1), 78-82. https://doi.org/10.1111/hdi.2000.4.1.78
Davenport, Andrew. "Central Venous Catheters for Hemodialysis: How to Overcome the Problems." Hemodialysis international. International Symposium on Home Hemodialysis vol. 4,1 (2000): 78-82. doi: https://doi.org/10.1111/hdi.2000.4.1.78
Davenport A. Central Venous Catheters for Hemodialysis: How to Overcome the Problems. Hemodial Int. 2000 Jan;4(1):78-82. doi: 10.1111/hdi.2000.4.1.78. PMID: 28455926.
Copy Download .nbib Format: NLM
Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature.

Medical gas research

Weaver J, Liu KJ.
PMID: 26306184
Med Gas Res. 2015 Aug 25;5:11. doi: 10.1186/s13618-015-0032-4. eCollection 2015.

Stroke, one of the most debilitating cerebrovascular and nuerological diseases, is a serious life-threatening condition and a leading cause of long-term adult disability and brain damage, either directly or by secondary complications. Most effective treatments for stroke are time...

Cite
Weaver J, Liu KJ. Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. Med Gas Res. 2015;5:11doi: 10.1186/s13618-015-0032-4.
Weaver, J., & Liu, K. J. (2015). Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. Medical gas research, 511. https://doi.org/10.1186/s13618-015-0032-4
Weaver, John, and Liu, Ke Jian. "Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature." Medical gas research vol. 5 (2015): 11. doi: https://doi.org/10.1186/s13618-015-0032-4
Weaver J, Liu KJ. Does normobaric hyperoxia increase oxidative stress in acute ischemic stroke? A critical review of the literature. Med Gas Res. 2015 Aug 25;5:11. doi: 10.1186/s13618-015-0032-4. eCollection 2015. PMID: 26306184; PMCID: PMC4547432.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 3022 entries